References
Kerr JR, Barr JG, Smyth ETM, et al. Technique for calculation of the true costs of antibiotic therapy. Eur J Clin Microbiol Infect Dis 1992; 11(9): 823–7
Davey P, Dodd T, Kerr S, et al. Audit of IV antibiotic administration. Pharm J 1990; 244: 793–6
Davey P, Malek M. Costs of hospital acquired infection. Pharm J 1991; 246 Suppl.: 12–4
Guglielmo J, Brooks GF. Antimicrobial therapy: cost-benefit considerations. Drugs 1989; 38: 473–80
Eisenberg JM, Koffer H, Glock HA, et al. What is the cost of nephrotoxicity associated with aminoglycosides? Ann Intern Med 1987; 107: 900–9
Davey P, Hernanz C, Lynch W, et al. Human and non-financial costs of hospital-acquired infection. J Hosp Infect 1991; 18 Suppl. A: 79–84
Daschner F. Unnecessary and ecological costs of hospital infection. J Hosp Infect 1991; 18 Suppl. A: 73–8
Smyth ETM, Barr JG, O’Neill CA, et al. An assessment of the hidden and total antibiotic costs of four parenteral cephalosporins. PharmacoEconomics 1995; 8(6): 541–50
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smyth, E.T.M., Barr, J.G. & Hogg, G.M. Hidden Costs of Antibiotics. Pharmacoeconomics 10, 99–100 (1996). https://doi.org/10.2165/00019053-199610010-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199610010-00010